Tazicef

Active Ingredient(s): Ceftazidime
FDA Approved: * March 6, 1986
Pharm Company: * HOSPIRA
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tazicef Overview

Ceftazidime, sold under the brand names Fortaz among others, is an antibiotic useful for the treatment of a number of bacterial infections.[1] Specifically it is used for joint infections, meningitis, pneumonia, sepsis, urinary tract infections, malignant otitis externa, Pseudomonas aeruginosa infection, and vibrio infection.[1] It is given by injection into a vein or muscle.[1] Common side effects include nausea, allergic reactions, and pain at...

Read more Tazicef Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ceftazidime

Recent Tazicef Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ceftazidime
  • Injection: 10g, 10gm/vial, 1g, 1g/50ml, 1gm/vial, 2g, 2g/50ml, 2gm/vial, 500mg, 500mg/vial, 6g, 6gm/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tazicef: (5 results)

Sorted by National Drug Code
  • 0409-5082 Tazicef 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5084 Tazicef 2 g/1 Intramuscular; Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5086 Tazicef 6 g/1 Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5092 Tazicef 20 mg/ml Intravenous Injection, Powder, for Solution by Hospira, Inc.
  • 0409-5093 Tazicef 40 mg/ml Intravenous Injection, Powder, for Solution by Hospira, Inc.

Other drugs which contain Ceftazidime or a similar ingredient: (6 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA